AN2 Therapeutics, Inc. (ANTX) quarterly income statement — complete revenue, gross profit & net income history
| Metric | Q1'26 | Q4'25 | Q3'25 | Q2'25 | Q1'25 | Q4'24 | Q3'24 | Q2'24 | Q1'24 | Q4'23 | Q3'23 | Q2'23 | Q1'23 | Q4'22 | Q3'22 | Q2'22 | Q1'22 | Q4'21 | Q1'21 |
|---|
| Sales/Revenue | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Revenue Growth % | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - |
| Cost of Goods Sold | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| COGS % of Revenue | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - |
| Gross Profit | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Gross Margin % | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - |
| Gross Profit Growth % | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - |
| Operating Expenses | 10.55M | 9.32M | 10.04M | 7.22M | 11.54M | 8.6M | 14.01M | 15.88M | 18.3M | 18.82M | 18.18M | 16.6M | 16.04M | 12.48M | 11.77M | 10.33M | 7.68M | 7.59M | 2.05M |
| OpEx % of Revenue | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - |
| Selling, General & Admin | 3.81M | 2.44M | 3.04M | 4.02M | 3.85M | 3.21M | 3.48M | 3.73M | 3.64M | 3.9M | 3.75M | 3.06M | 4.05M | 3.72M | 3.34M | 3.63M | 2.05M | 1.78M | 401K |
| SG&A % of Revenue | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - |
| Research & Development | 6.74M | 6.88M | 7M | 3.2M | 7.69M | 5.4M | 8.29M | 12.15M | 14.65M | 14.92M | 14.43M | 13.54M | 11.98M | 8.75M | 8.43M | 6.7M | 5.63M | 5.81M | 1.65M |
| R&D % of Revenue | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - |
| Other Operating Expenses | 0 | 0 | 0 | 0 | 0 | -9K | 1000K | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Operating Income | -10.55M | -9.32M | -10.04M | -7.22M | -11.54M | -8.6M | -14.01M | -15.88M | -18.3M | -18.82M | -18.18M | -16.6M | -16.04M | -12.48M | -11.77M | -10.33M | -7.68M | -7.59M | -2.05M |
| Operating Margin % | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - |
| Operating Income Growth % | 8.55% | -8.35% | 28.36% | 54.56% | 36.94% | 54.3% | 22.92% | 4.34% | -14.07% | -50.81% | -54.46% | -60.66% | -108.76% | -64.29% | - | - | -274.78% | - | - |
| EBITDA | -10.03M | -10M | -9.35M | -7.22M | -11.54M | 9K | -11.77M | 9.53M | -18.3M | -16.9M | 0 | -16.6M | 0 | -12.48M | -11.77M | -10.33M | -7.68M | 0 | -2.05M |
| EBITDA Margin % | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - |
| EBITDA Growth % | 13.08% | -111244.44% | 20.54% | -175.73% | 36.94% | 100.05% | - | 157.39% | - | -35.44% | 100% | -60.66% | 100% | - | - | - | -274.78% | - | - |
| D&A (Non-Cash Add-back) | 0 | 0 | 0 | 0 | 0 | 8.61M | 0 | 25.41M | 0 | 0 | 18.18M | 0 | 16.04M | 0 | 0 | 0 | 0 | 7.59M | 0 |
| EBIT | -10.03M | -10M | -9.35M | -7.22M | -11.54M | -8.61M | -11.77M | -15.88M | -18.3M | -16.9M | -18.18M | -16.6M | -16.04M | -12.48M | -11.77M | -10.33M | -7.68M | -7.59M | -2.05M |
| Net Interest Income | 523K | 605K | 687K | 754K | 888K | 0 | 0 | 0 | 1.68M | 0 | 0 | 0 | 0 | 630K | 466K | 228K | 27K | 27K | 2K |
| Interest Income | 523K | 605K | 687K | 754K | 888K | 0 | 0 | 0 | 1.68M | 0 | 0 | 0 | 0 | 630K | 466K | 228K | 27K | 27K | 2K |
| Interest Expense | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Other Income/Expense | 523K | 606K | 687K | 754K | 888K | 1.08M | 1.27M | 1.45M | 1.68M | 1.92M | 1.47M | 797K | 716K | 634K | 431K | 213K | 28K | 49K | 2K |
| Pretax Income | -10.03M | -8.71M | -9.35M | -6.46M | -10.65M | -7.52M | -12.75M | -14.44M | -16.62M | -16.9M | -16.71M | -15.8M | -15.32M | -11.84M | -11.34M | -10.12M | -7.66M | -7.54M | -2.05M |
| Pretax Margin % | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - |
| Income Tax | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Effective Tax Rate % | 0% | 0% | 0% | 0% | 0% | 0% | 0% | 0% | 0% | 0% | 0% | 0% | 0% | 0% | 0% | 0% | 0% | 0% | 0% |
| Net Income | -10.03M | -8.71M | -9.35M | -6.46M | -10.65M | -7.52M | -12.75M | -14.44M | -16.62M | -16.9M | -16.71M | -15.8M | -15.32M | -11.84M | -11.34M | -10.12M | -7.66M | -7.54M | -2.05M |
| Net Margin % | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - |
| Net Income Growth % | 5.83% | -15.79% | 26.63% | 55.23% | 35.91% | 55.49% | 23.7% | 8.66% | -8.44% | -42.7% | -47.34% | -56.17% | -100.17% | -56.95% | - | - | -273.78% | - | - |
| Net Income (Continuing) | -10.03M | -8.71M | -9.35M | -6.46M | -10.65M | -7.52M | -12.75M | -14.44M | -16.62M | -16.9M | -16.71M | -15.8M | -15.32M | -11.84M | -11.34M | -10.12M | -7.66M | -7.54M | -2.05M |
| Discontinued Operations | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Minority Interest | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| EPS (Diluted) | -0.29 | -0.29 | -0.31 | -0.21 | -0.35 | -0.25 | -0.43 | -0.48 | -0.56 | -0.57 | -0.65 | -0.81 | -0.75 | -0.66 | -0.56 | -0.52 | -0.40 | -0.42 | -0.20 |
| EPS Growth % | 17.14% | -16% | 27.91% | 56.25% | 37.5% | 56.14% | 33.85% | 40.74% | 25.33% | 13.64% | -16.07% | -55.77% | -87.5% | -57.14% | - | - | -100% | - | - |
| EPS (Basic) | -0.29 | -0.29 | -0.31 | -0.21 | -0.35 | -0.25 | -0.43 | -0.48 | -0.56 | -0.57 | -0.65 | -0.81 | -0.75 | -0.66 | -0.56 | -0.52 | -0.40 | -0.42 | -0.20 |
| Diluted Shares Outstanding | 34.06M | 30.22M | 30.28M | 30.17M | 30.05M | 29.88M | 29.84M | 29.82M | 29.76M | 29.73M | 25.64M | 19.5M | 19.39M | 19.4M | 19.35M | 19.26M | 19M | 18.14M | 14.05M |
| Basic Shares Outstanding | 34.06M | 30.22M | 30.28M | 30.17M | 30.05M | 29.88M | 29.84M | 29.82M | 29.76M | 29.73M | 25.64M | 19.5M | 19.39M | 19.4M | 19.35M | 19.26M | 19M | 18.14M | 14.05M |
| Dividend Payout Ratio | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - |